CancerFree Biotech
Developer of a circulating tumor cell-derived organoid platform designed to accurately predict patient responses to cancer therapies. The company has developed a technology based on circulating tumor ...
Valuation
$0
Share Price
N/A
Total Raised
$2.1M
Last Round
N/A